MARLENE DELEON-GARCIA: Open Payments
NPI 1255672747 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$642 in 26 payments from 15 companies in 2025. Trend: 2023 $34 · 2024 $138 · 2025 $642
Food & beverage: $642
| Company | Payments | Amount |
|---|---|---|
| SOBI, INC | 4 | $94 |
| Incyte Corporation | 3 | $74 |
| AstraZeneca Pharmaceuticals LP | 2 | $48 |
| Novartis Pharmaceuticals Corporation | 2 | $48 |
| GENZYME CORPORATION | 2 | $47 |
| PharmaEssentia USA Corporation | 2 | $45 |
| Lilly USA, LLC | 2 | $44 |
| Eisai Inc. | 2 | $41 |
| Novocure Inc. | 1 | $39 |
| Gilead Sciences, Inc. | 1 | $34 |
Products named: Doptelet, ENHERTU, KISQALI, JAKAFI, BESREMI, VERZENIO, Lenvima, Optune Lua (NovoTTF-200T).
Industry payments across FL — which companies pay providers there.
